pharmaphorum

AUGUST 17, 2020

Clearly, over the last few months, sales reps have had limited in-person access to HCPs, which has presented a challenge. “A Interactions between sales reps and HCPs has shifted to more digital forms of communication as a result of the lack of face-to-face interaction. Joanna Carlish. Personalising marketing content.

Communication 92

Communication Insurance Packaging Pharmaceutical Companies 92

European Pharmaceutical Review

JANUARY 25, 2024

7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 Even in countries with high smartphone usage such as Denmark, up to 25 percent of the population do not possess a smartphone.

Packaging 79

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 79

Pharmaceutical Technology

NOVEMBER 9, 2022

The potential benefits from linking these data streams to AI, meanwhile, cannot be overstated – offering opportunities to predict future scenarios as well as fine-tune orders in the present. As Palmadottir says: “having better technology means we will have better connectivity in real time, and a better network for communication.”

Vaccines 52

Vaccines Packaging Communication 52

pharmaphorum

APRIL 11, 2022

Such therapies present significant challenges to our current regulatory and access processes, but these are challenges we must overcome if patients are to benefit. Data will always be central to everything we do, as it has the power to communicate the potential of a new treatment to change a person’s life.

Pharmaceutical Companies 114

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 114

ISPE

OCTOBER 26, 2022

Reintroducing the liaison role of International Board members with individual Chapters and Affiliates has given us direct lines of communication to the mutual benefit of the International Board and the local groups. Shortly after that, I spoke for ISPE at an event in Italy.

Packaging 52

Packaging Compounding Communication Vaccines 52

European Pharmaceutical Review

NOVEMBER 24, 2022

Tackling pharmaceutical counterfeiting continues, therefore, to be a clear and present priority for manufacturers, healthcare authorities and law enforcement. One area in which the problem can be tackled effectively is product packaging. Covert-hologram seals are also atracting interest within the pharmaceutical packaging sector.

Packaging 95

Packaging Labelling Documentation Dosage 95

pharmaphorum

AUGUST 1, 2022

Ties Kroezen, venture leader of Community Life Centers and business development manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.

Packaging 78

Packaging Insurance Communication Hospitals 78

European Pharmaceutical Review

JUNE 24, 2022

Stakeholders in the EU often use the risk-adjusted Net Present Value (rNPV) investment model to determine whether to invest in a pharmaceutical product. This obviously presents a huge magnitude of risk for drug developers,” he noted. It is too early to say because we have not seen the whole package of measures yet. References.

Compounding 96

Compounding Packaging Dosage Communication 96

pharmaphorum

MARCH 16, 2022

Future onsite-and-online conferences present significant decision-making challenges to the pharmaceutical industry, amply demonstrated by the sponsored symposia options, shown in Figure 5, which were available at the 2021 EAACI hybrid conference. Figure 5 Sponsored symposia options at the EAACI hybrid congress 2021.

Communication 98

Communication Packaging 98

European Pharmaceutical Review

JANUARY 23, 2023

MSSG stresses the importance of transparency in relation to shortages and highlights the need for all stakeholders to communicate in an objective and responsible way to avoid any undue public concern. In addition, MSSG supports temporary national measures such as unit dose dispensing and compounding.

Packaging 92

Packaging Compounding Labelling Communication 92

ISPE

OCTOBER 28, 2022

Glass ampoules, as illustrated in Figure 1, offer protection against air and contaminations and are widely used as the primary packaging for pharmaceutical drugs. In this project, the ampoules are smoothly rotated and presented to the tip inspection stations, which encompasses the pre-process automation step. Project Scope.

Labelling 52

Labelling Pharmaceutical Companies Pharmaceutical Companies Packaging 52

pharmaphorum

MAY 24, 2021

It can be used for sales, marketing and patient communication materials, in print or digital form. It means that designs can be carried out in a more templated fashion than at present and presents a change from marketing-as-usual.

Communication 94

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 94

Pharmaceutical Technology

FEBRUARY 3, 2023

One important advancement will involve tackling the still-present issue of empty capsids, for example. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. We may still continue to send you service-related and other non-promotional communications. 1] BioNews. Hemophilia News Today. link] [2] Tang Q, et al.

Communication 97

Communication Packaging Dosage Vaccines 97

pharmaphorum

NOVEMBER 29, 2021

From clear communication with an unsettled, dispersed workforce to maintaining positive energy and managing people’s working hours, the need for open, inclusive and empathetic leadership has never been more important. . iii] It’s no longer just about the company, compensation package and secondary benefits (e.g., gym membership).

Communication 95

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 95

ISPE

MAY 11, 2023

defines a service-oriented architecture (SOA) where application components provide services to the other components through a communication protocol over a network. The goal is to break down complex processes into easy-to-grasp packages, including data privacy and information technology (IT) security. to Industry 4.0 2 3 a b Hankel, M.,

Packaging 52

Packaging Documentation Communication Data Entry 52

ISPE

MARCH 8, 2023

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

IDStewardship

NOVEMBER 29, 2023

I was always the technologist training someone, giving information about package inserts about the behind the scenes , talking about why do we do this or why do we do that and that’s the way that I am. I talk to people presenting posters, reach out to speakers, and I give things like stickers with the podcast logo and QR code.

Patient Care 222

Patient Care Hospitals Packaging Communication 222

ISPE

SEPTEMBER 11, 2023

This article presents relevant insights on the current regulatory and technical landscape for decentralized manufacturing, with select examples of current applications, and discusses perspectives on evolving and adapting the current regulations to meet future capabilities. Nature Communications 12, no. Biotechnology Progress 36, no.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 7, 2023

As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging. 9 December 2021.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

ISPE

MARCH 29, 2023

Application of this innovative approach will quickly orient regulators to the content of Module 3, “present product quality benefit-risk considerations, summarize the pharmaceutical development, present an overall understanding of the product quality,” 1 and facilitate continuous improvement. Section 3.2.S.2.6

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

Application of this innovative approach will quickly orient regulators to the content of Module 3, “present product quality benefit-risk considerations, summarize the pharmaceutical development, present an overall understanding of the product quality,” 1 and facilitate continuous improvement. Section 3.2.S.2.6

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

SEPTEMBER 11, 2023

x, a free and open-source computational fluid dynamics (CFD) software package. In Figure 3, a set of velocity simulation pictures and the results of the air velocity measurement in the real isolator are presented. You may unsubscribe from these ISPE communications at any time. m/s (dark red).

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

MAY 9, 2023

However, existing, or new local regulatory requirements still present hurdles and the regulators’ intention to embrace ICH guidelines or to accept alternate risk-based, scientifically supported approaches may be interpreted negatively by global pharmaceutical companies.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

The Thyroid Pharmacist

OCTOBER 27, 2023

Follow package instructions. These signals create communication and function within nerves and muscles, as the electrolytes move in or out of cells. Follow package directions for each supplement. The herb itself can be poisonous if ingested. They’re great for injuries, overuse, or soreness from workouts.

Health and Personal Care Stores 66

Health and Personal Care Stores Immunization Compounding Packaging 66

ISPE

JANUARY 10, 2023

This article presents a proposed regulatory strategy to help alleviate supply risks for approved therapeutics. The strategy is to provide an appropriate characterization package that demonstrates the alternative filter or resin will not impact product quality, submit it in a PAS, and, if needed, submit a request for an expedited review.

Packaging 52

Packaging FDA Communication Vaccines 52

Pharma Marketing Network

OCTOBER 27, 2020

you say there’s access to all sorts of University high-end University courses and classes on writing and communication among a thousand other topics could you touch a little bit on that and give us some insight into how you hacked your own education in your journey to becoming a thought leader? Robin (Guest): Yup.

Hospitals 52

Hospitals Packaging Communication 52

Pharma Marketing Network

OCTOBER 27, 2020

you say there’s access to all sorts of University high-end University courses and classes on writing and communication among a thousand other topics could you touch a little bit on that and give us some insight into how you hacked your own education in your journey to becoming a thought leader? Robin (Guest): Yup.

Hospitals 52

Hospitals Packaging Communication 52

ISPE

AUGUST 30, 2022

In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Finally, the DP is packaged in a suitable container to ensure continued quality. Present in sufficient quantity to achieve target concentration in process and enable defoaming.

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

MARCH 6, 2023

link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceutical companies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. recycled content in packaging, reduction of packaging weights).

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

OCTOBER 27, 2022

As a result, some companies have challenged the paradigm by forgoing lyophilization entirely, opting to provide solution phase API to drug product facilities for filling and packaging. You may unsubscribe from these ISPE communications at any time. Getting More from Facilities. Conclusion. Leave this field blank.

Process Improvement 98

Process Improvement Packaging Dosage Compounding 98

ISPE

AUGUST 29, 2022

Such changes can include increasing batch sizes, adding manufacturing facilities, creating new product presentations, and updating analytical methods. This information package is then submitted in electronic PDF format that health authorities must manually “unpack” or deconstruct in order to perform their assessments.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

MARCH 7, 2023

Representatives from R&D, manufacturing and supply, and commercial should all be included at the top-level forum, along with the main functions needed for delivery such as the sustainability group, engineering, procurement, legal, and corporate communications. Communicating keynote successes will help encourage engagement and support.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

OCTOBER 27, 2022

Each vector modality presents distinct values in the current range of therapeutic entities, clinical indications, cells to be modified, and evolving manufacturing methods. Figure 3 presents a series of adjacency diagrams that depict the potential approach to multimodal facility design based on the preceding discussion.

Packaging 52

Packaging Communication Immunization Vaccines 52

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

MARCH 22, 2023

You also need to create an attractive climate for the people that you want to have for these kinds of initiatives to want to locate and be present in the European Union.” The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

FEBRUARY 7, 2023

It is important to devise a plan as early as possible, starting with an assessment of the overall landscape and the opportunities and challenges presented. While there are some similarities and patterns, the overriding fragmentation of the European market means that a successful access strategy must be country-tailored.

Packaging 52

Packaging Insurance Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 12, 2023

Kevin Bond: Lyophilization can allow for temperature sensitive drug products to be stored for longer periods of time, and at higher temperatures, compared to a similar liquid presentation of the product since they are stored in a dry state. Solid state reactions occur much more slowly than liquid interactions. A great example is aspirin.

Packaging 52

Packaging Communication Vaccines 52